Sandra Jernström
Impact in
-
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Cells and Metastasis
Papers in
-
- MicroRNA in disease regulation 1
- Oncology 2
- Cancer Cells and Metastasis 1
- HER2/EGFR in Cancer Research 1
- Co-authors
- Kristine Kleivi Sahlberg (6 shared papers)Merja Perälä (2 shared papers)Olli Kallioniemi (2 shared papers)Vesa Hongisto (2 shared papers)John-Patrick Mpindi (1 shared paper)Vidal Fey (1 shared paper)Ole Christian Lingjærde (4 shared papers)Eldri U. Due (4 shared papers)
- Journals
- PLoS ONE (1 paper)Breast Cancer Targets and Therapy (1 paper)European Journal of Cancer (1 paper)Genome Medicine (1 paper)Breast Cancer Research (1 paper)
- Partner nations
- NorwayUnited StatesFinland
In The Last Decade
Sandra Jernström
6 papers receiving 271 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 78
- Oncology 86
- Internal Medicine 10
- Biophysics 15
- Biomedical Engineering 83
Countries citing papers authored by Sandra Jernström
This map shows the geographic impact of Sandra Jernström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Jernström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Jernström more than expected).
Fields of papers citing papers by Sandra Jernström
This network shows the impact of papers produced by Sandra Jernström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Jernström. The network helps show where Sandra Jernström may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Jernström, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 140 | |
| 2 | 2016 | 57 | |
| 3 | 2015 | 30 | |
| 4 | 2015 | 25 | |
| 5 | 2017 | 24 | |
| 6 | 2014 | 1 | |
| 7 | 2022 | 0 |
About Sandra Jernström
Sandra Jernström is a scholar working on Cancer Research, Oncology, Biomedical Engineering, Molecular Biology and Automotive Engineering, having authored 7 papers that have together received 277 indexed citations. Recurring topics across this work include 3D Printing in Biomedical Research (2 papers), Blood Coagulation and Thrombosis Mechanisms (1 paper), Metabolomics and Mass Spectrometry Studies (1 paper), MicroRNA in disease regulation (1 paper), Cancer Cells and Metastasis (1 paper), Additive Manufacturing and 3D Printing Technologies (1 paper), HER2/EGFR in Cancer Research (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Cancer Research (78 citations), Oncology (86 citations), Internal Medicine (10 citations), Biophysics (15 citations) and Biomedical Engineering (83 citations). Sandra Jernström has collaborated with scholars based in Norway, United States and Finland. Frequent co-authors include Kristine Kleivi Sahlberg, Merja Perälä, Olli Kallioniemi, Vesa Hongisto, John-Patrick Mpindi, Vidal Fey, Ole Christian Lingjærde, Eldri U. Due, Marit Krohn and Miriam R. R. Aure. Their work appears in journals such as PLoS ONE, Breast Cancer Targets and Therapy, European Journal of Cancer, Genome Medicine and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.